Navigation Links
Continued Funding to Help Advance 'Exciting Moment' in Diabetes Research
Date:4/30/2008

American Diabetes Association and Richard and Susan Smith Family Foundation Announce Renewed Commitment to Diabetes Gene Study

ALEXANDRIA, Va., April 30 /PRNewswire-USNewswire/ -- The American Diabetes Association (ADA) has announced research projects to study newly discovered human type 2 diabetes genes in mice, and potentially find new drug molecules that can treat the genetic causes of type 2 diabetes. The projects will be funded through a renewed partnership -- between the ADA/Richard and Susan Smith Family Foundation Pinnacle Program Project Award -- of more than $2 million over three years.

Evan Rosen, MD, PhD, of Beth Israel Deaconess Medical Center in Boston, and Vamsi K. Mootha, MD, of Harvard University are lead researchers for the grant projects. Dr. Rosen's study Humanized Mouse Models of Type 2 Diabetes will focus on whether mouse models with human diabetes genes will have beneficial effects on glucose control. Dr. Mootha's project Cellular Models of Human Type 2 Diabetes Genes will study whether markers can be established to monitor therapeutic responses. This grant will expand on the foundation that the first Pinnacle Program Project, Systematic identification of pathways contributing to diabetes and obesity, set forth.

Research from the Foundation's initial grant led to the discovery of five new genes associated with type 2 diabetes, as well as one for obesity and one for triglyceride levels (a component of blood cholesterol). The discoveries were found with the use of a new and powerful approach to diabetes research developed based on contributions by the group, whole genome association studies (WGAS).

"The discoveries of these researchers have contributed greatly to our knowledge of genes influencing diabetes and to a lesser extent obesity," commented Cathy Bernstein, Chair, ADA Research Foundation. "The novel genes identified by this approach were completely unexpected from previous knowledge, and have opened up new windows into the biology of these diseases."

"This is a truly exciting moment, with great possibilities for building and expanding on these successes," commented Scott Campbell, ADA Vice President of Research. "These newly discovered genes provide leads that must be followed to decipher the causes of type 2 diabetes and to obtain clues for improving prevention and treatment."

The Richard and Susan Smith Family Foundation Pinnacle Program Project Award was established to stimulate new collaborations among investigators working on independent but complementary research projects aimed at developing methods of preventing type 2 diabetes.

About the American Diabetes Association

The American Diabetes Association is the nation's premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association has offices in every region of the country, providing services to hundreds of communities. The Association's commitment to research is reflected through its scientific meetings; education and provider recognition programs; and its Research Foundation and Nationwide Research Program, which fund breakthrough studies looking into the cure, prevention, and treatment of diabetes and its complications. The American Diabetes Association Research Foundation was created to raise support for diabetes research conducted within the Nationwide Research Program. One hundred percent of all Research Foundation contributions go directly to diabetes research. All non-research costs associated with the Research Program are paid for through the Association's general fund.

For more information, please visit http://www.diabetes.org or call 1-800-DIABETES (1-800-342-2383). Information from both these sources is available in English and Spanish.


'/>"/>
SOURCE American Diabetes Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
9. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
10. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
11. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... 2016   Bernstein Liebhard LLP today announced that ... States District Court for the District of Arizona ... of all persons or entities who purchased common shares of ... ) from March 3, 2015 through January 25, 2016 (the ... officers with violations of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... LODI, N.J. , Feb. 4, 2016  Montoya ... Pinnacle Professional in the field of Pharmaceuticals. Montoya is ... . ... and supplies, Becton Dickinson provides healthcare institutions, ... medical equipment throughout fifty countries across the globe. ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced that ... donate to Give To Cure’s campaign that is crowdfunding clinical trials to help find ... share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... CitiDent, announces that it is now welcoming orthodontist, Dr. Amanda Cheng, to ... a complete range of oral health care, including general dentistry, cosmetic treatments, periodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic ... in the event they are experiencing an illness. Migraines are a severe form of ... afflicted with migraines would not wish the pain on their worst enemy, the feeling ...
(Date:2/5/2016)... ... , ... Calls Blacklist has just been updated by mobile app developer Vlad ... has fixed known bugs within the app. Calls Blacklist allows its users to only ... any of their device’s battery power or memory. It provides a powerful call blocker ...
Breaking Medicine News(10 mins):